FilingSEC EDGAR6-K
Adagene Expands Collaboration with Third Arc Bio and Selects First Lead Candidate
· SEC accepted
Stagepreclinical
Filing content
The company amended its strategic collaboration with Third Arc Bio and selected the first lead candidate utilizing its SAFEbody technology.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…